Hormone replacement therapy and reduced cognitive decline in older women - The Cache County Study

被引:89
|
作者
Carlson, MC
Zandi, PP
Plassman, BL
Tschanz, JT
Welsh-Bohmer, KA
Steffens, DC
Bastian, LA
Mehta, KM
Breitner, JCS
机构
[1] Johns Hopkins Univ, Ctr Aging & Hlth, Dept Mental Hyg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA
[3] Utah State Univ, Dept Psychol, Logan, UT 84322 USA
[4] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Internal Med, Durham, NC 27710 USA
[6] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA
[7] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA
关键词
D O I
10.1212/WNL.57.12.2210
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine the association between postmenopausal hormone replacement therapy (HRT) and the trajectory of global cognitive change with age. Methods: The Modified Mini-Mental State Examination (MMSE) was administered to a population sample of 2,073 nondemented, community-dwelling female residents of Cache County, UT, aged 65 and older. Current and past HRT and other medications at a baseline interview and at follow-up 3 years later were assessed. Between interviews, a telephone Women's Health Questionnaire was administered to assess initial exposure, duration, and recency of HRT. Generalized estimating equation marginal models were used to evaluate the cross-sectional and longitudinal relations of HRT and modified MMSE score. Also assessed were effects with multivitamins and calcium supplements as exposures likely to reflect a "healthy lifestyle" among HRT users. Model covariates included the presence of APOE epsilon4 alleles, age, education, concurrent depression, several chronic diseases, and self-perceived general health. Results: Age, lower education, depression, and APOE epsilon4 were all associated with lower baseline modified MMSE scores. With these covariates in the model, lifetime HRT use was associated with better baseline modified MMSE scores and a slower rate of decline. Stratification by APOE genotype did not alter these effects. Apparent benefits with HRT were attenuated but remained significant after elimination of scores from participants with incident dementia. A significant interaction between age and HRT indicated the strongest effects in women aged 85 and older. Measures of age at initial use of HRT, duration, and recency of exposure did not improve the models. No effects were seen with the "healthy lifestyle" control exposures. Conclusions: In a population cohort of older women, lifetime FIRT exposure was associated with improved global cognition and attenuated decline over a 3-year interval. Improvements were greatest in the oldest old.
引用
收藏
页码:2210 / 2216
页数:7
相关论文
共 50 条
  • [1] Hormone replacement therapy and incidence of Alzheimer disease in older women - The Cache County Study
    Zandi, PP
    Carlson, MC
    Plassman, BL
    Welsh-Bohmer, KA
    Mayer, LS
    Steffens, DC
    Breitner, JCS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (17): : 2123 - 2129
  • [2] Estrogen replacement therapy and cognitive decline in older community women
    Matthews, K
    Cauley, J
    Yaffe, K
    Zmuda, JM
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (05) : 518 - 523
  • [3] Q/Does hormone replacement therapy prevent cognitive decline in postmenopausal women?
    Gates, Madeline
    Beagle, Melissa
    Bull, Lauren
    Radi, Roxanne
    Lyon, Corey
    DeSanto, Kristen
    JOURNAL OF FAMILY PRACTICE, 2023, 72 (04): : E10 - E11
  • [4] Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study
    Burhanullah, Muhammad Haroon
    Tschanz, JoAnn T.
    Peters, Matthew E.
    Leoutsakos, Jeannie-Marie
    Matyi, Joshua
    Lyketsos, Constantine G.
    Nowrangi, Milap A.
    Rosenberg, Paul B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (01): : 64 - 71
  • [5] A LONGITUDINAL STUDY OF MEMORY DECLINE IN ELDERLY WOMEN WITH AND WITHOUT HORMONE REPLACEMENT THERAPY
    Ober, Beth A.
    Shenaut, Gregory K.
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2013, : 226 - 226
  • [6] Diabetes mellitus and cognitive decline in the Cache County study on memory, health and aging
    Charoonruk, G
    Munger, R
    Wengreen, H
    Corcoran, C
    Tschanz, J
    Norton, M
    Bastian, L
    Welsch-Bohmer, K
    NEUROBIOLOGY OF AGING, 2004, 25 : S475 - S475
  • [7] Hormone replacement therapy and stroke risk in older women
    Fung, MM
    Barrett-Connor, E
    Bettencourt, RR
    JOURNAL OF WOMENS HEALTH, 1999, 8 (03) : 359 - 364
  • [8] Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women
    Kohrt, WM
    Landt, M
    Birge, SJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11): : 3980 - 3985
  • [9] Hormone replacement therapy for cognitive function in postmenopausal women
    Lethaby, A.
    Hogervorst, E.
    Richards, M.
    Yesufu, A.
    Yaffe, K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [10] Hormone replacement therapy and cognitive function in postmenopausal women
    Kurt, M
    Bekçi, B
    Karakas, S
    MATURITAS, 2006, 53 (01) : 39 - 48